Skip to main content

Peer Review reports

From: Human health benefit and burden of the schizophrenia health care pathway in Belgium: paliperidone palmitate long-acting injections

Original Submission
1 Nov 2017 Submitted Original manuscript
23 Nov 2017 Author responded Author comments - Sam Debaveye
Resubmission - Version 2
23 Nov 2017 Submitted Manuscript version 2
16 Apr 2018 Reviewed Reviewer Report - Mary Lou Chatterton
26 Apr 2018 Reviewed Reviewer Report - Katarzyna Wyka
18 May 2018 Author responded Author comments - Sam Debaveye
Resubmission - Version 3
18 May 2018 Submitted Manuscript version 3
3 Jun 2018 Reviewed Reviewer Report - Mary Lou Chatterton
10 Apr 2019 Reviewed Reviewer Report - Research Square
9 May 2019 Author responded Author comments - Sam Debaveye
Resubmission - Version 4
9 May 2019 Submitted Manuscript version 4
16 May 2019 Reviewed Reviewer Report - Research Square
6 Jun 2019 Author responded Author comments - Sam Debaveye
Resubmission - Version 5
6 Jun 2019 Submitted Manuscript version 5
Publishing
12 Jun 2019 Editorially accepted
19 Jun 2019 Article published 10.1186/s12913-019-4247-2

You can find further information about peer review here.

Back to article page